Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cisterna Biologics
AddedMar 22, 2024
UpdatedJul 7, 2026
Cisterna Biologics

Cisterna Biologics

Seed

Cisterna Biologics enhances mRNA quality for therapeutics using proprietary tech.

HQ
Carlsbad, CA, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorS22
Overview
Compare
Fundraising
Employees
Website

Founded in 2022 and based in San Diego, California, Cisterna Biologics is dedicated to advancing mRNA-based therapeutics. The company's core mission is to address critical challenges in the biotech industry related to the quality, quantity, longevity, and cost of mRNA. Cisterna Biologics utilizes proprietary technologies to enhance mRNA quality, aiming to unlock the full potential of mRNA as a therapeutic tool. Their market focus includes pharmaceutical companies and research institutions seeking high-quality mRNA solutions.

Cisterna Biologics has attracted notable investors and industry experts who recognize the transformative potential of their technology. While specific names are not disclosed, the company's innovative approach has garnered attention within the biotech community. Key achievements include the development of proprietary methods that significantly improve mRNA purity and stability. Cisterna Biologics' impact is seen in its contribution to making mRNA-based treatments more viable and accessible, potentially revolutionizing therapeutic applications.

Cisterna Biologics - Similar Companies

Sensible Biotechnologies logo

Sensible Biotechnologies

sensible.bio

ParcelBio logo

ParcelBio

parcelbio.com

Serna Bio logo

Serna Bio

serna.bio

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Rnaimmune logo

Rnaimmune

rnaimmune.com

Excepgen logo

Excepgen

excepgen.com

UTR Therapeutics logo

UTR Therapeutics

Catena Biosciences logo

Catena Biosciences

Synvivia logo

Synvivia

synvivia.com

Locanabio logo

Locanabio

Combined Therapeutics logo

Combined Therapeutics

combinedtx.com

Curie.Bio logo

Curie.Bio

curie.bio

Strm.Bio logo

Strm.Bio

strm.bio

EpiBiologics logo

EpiBiologics

epibiologics.com

Nuntius Therapeutics logo

Nuntius Therapeutics

nuntiustx.com

Cisterna Biologics - Quick Facts

Who are Cisterna Biologics' competitors?

Companies similar to Cisterna Biologics include Sensible Biotechnologies, ParcelBio, Serna Bio and Andson Biotech.

When was Cisterna Biologics founded?

Cisterna Biologics was founded in 2022.

Where is Cisterna Biologics' headquarters located?

Cisterna Biologics' headquarters is located in Carlsbad, CA, US.

When was Cisterna Biologics' last funding round?

Cisterna Biologics' most recent funding round was for $500k (USD) in August 2022.

How much has Cisterna Biologics raised to-date?

As of Aug 22, 2022, Cisterna Biologics has raised a total of $500k (USD).

How many employees does Cisterna Biologics have?

Cisterna Biologics has 2 employees as of Apr 6, 2024.

Cisterna Biologics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software